This episode currently has no reviews.
Submit ReviewWe're back with another check-in on new companies discussed last year!
In this episode we look at results from GoodRx, Inari, and Amwell.
Stocks: AMWL, GDRX, NARI
Check out more of our content here:
StockUp, The Motley Fool's weekly email newsletter
Reach us by Email @ IndustryFocus@fool.com
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review